cladribine has been researched along with Marchiafava-Micheli Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, M; Kawa, K; Nakayama, M; Sawada, A; Yamada, K; Yasui, M | 1 |
| Kanai, S; Kanda, Y; Makimoto, A; Mineishi, S; Miyawaki, S; Nakai, K; Niiya, H; Ohnishi, M; Ohnishi, T; Saito, A; Saito, T; Suenaga, K; Takaue, Y; Takeuchi, T; Tanosaki, R; Tobinai, K | 1 |
2 other study(ies) available for cladribine and Marchiafava-Micheli Syndrome
| Article | Year |
|---|---|
Severe persistent bone marrow failure following therapy with 2-chlorodeoxyadenosine for relapsing juvenile xanthogranuloma of the brain.
Topics: Anemia, Aplastic; Bone Marrow Diseases; Bone Marrow Failure Disorders; Bone Marrow Transplantation; Brain Diseases; Child; Cladribine; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Prognosis; Recurrence; Transfusion Reaction; Xanthogranuloma, Juvenile | 2012 |
Successful application of nonmyeloablative transplantation for paroxysmal nocturnal hemoglobinuria.
Topics: Antilymphocyte Serum; Busulfan; Cladribine; Cyclosporine; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Histocompatibility; Humans; Immunosuppressive Agents; Male; Middle Aged; Transplantation Conditioning; Transplantation, Homologous | 2001 |